Status:
COMPLETED
Effect of Weekly High-dose Vitamin D3 Supplementation on the Association Between Circulatory FGF-23 and A1c Levels
Lead Sponsor:
Applied Science Private University
Conditions:
Diabetes Mellitus, Type 2
Kidney Diseases
Eligibility:
All Genders
22-55 years
Phase:
NA
Brief Summary
Among Jordanians, there is a high prevalence of T2DM. VDD has also spread rapidly in the past decade. Preliminary results of recent studies have shown that VD3 has a potential role in reducing FBG. No...
Detailed Description
Among Jordanians, there is a high prevalence of T2DM. VDD has also spread rapidly in the past decade. Preliminary results of recent studies have shown that VD3 has a potential role in reducing FBG. No...
Eligibility Criteria
Inclusion
- Inclusion criteria included males and females in the age range of 22-55 years with a medical diagnosis of vitamin D deficiency.
Exclusion
- subjects with any chronic disease such as kidney failure, CVD, diabetes, blood disorders, or immune problems, including autoimmune diseases, chronic or severe infections will be excluded.
Key Trial Info
Start Date :
December 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 20 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04682626
Start Date
December 25 2020
End Date
March 20 2021
Last Update
March 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mahmoud S Abu-Samak
Amman, Jordan